
Jieun Lee
Articles
-
Aug 9, 2024 |
medium.com | Jieun Lee
In recent times, my focus has been on self-mastery and healing the deep-seated wounds that have weighed heavily on me. This much-dreaded East Coast trip, however, turned out to be transformative in ways I hadn’t anticipated. What I learned from this journey is the profound impact of the stories we choose to tell ourselves. By shifting this narrative, everything changes. The Painful Past with My FatherI harbored deep resentment towards my father.
-
Apr 15, 2024 |
pubs.rsc.org | Jieun Lee |Chen Zhao |Changhong Wang |Anna Chen
Bridging the gap between academic research and industrial development in advanced all-solid-state lithium–sulfur batteries The energy storage and vehicle industries are heavily investing in advancing all-solid-state batteries to overcome critical limitations in existing liquid electrolyte-based lithium-ion batteries, specifically focusing on mitigating fire hazards and improving energy density.
-
Nov 14, 2023 |
bis.org | Jieun Lee
FocusThis paper examines how the US dollar affects government bond liquidity in Korea, a representative emerging market economy (EME), and when the effects become more pronounced. I highlight how the limited intermediation capacity of EME dealers can dampen liquidity through tightened funding liquidity conditions and financial channels of exchange rates.
-
Sep 29, 2023 |
mdpi.com | Jieun Lee |Hye Soo Park |Hee Jin Jung |Yu Jung Park
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
-
Feb 15, 2023 |
mdpi.com | Jieun Lee
Abstract:Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancers and is characterized by an aggressive nature and a high rate of recurrence despite neoadjuvant and adjuvant chemotherapy. Although novel agents are constantly being introduced for the treatment of breast cancer, conventional cytotoxic chemotherapy based on anthracyclines and taxanes is the mainstay treatment option for TNBC.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →